Latest filing published 24 Jul 2009 for Seelos Therapeutics, INC., €185k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jacob May: trading record in brief
All filings by Jacob May on record concern Seelos Therapeutics, Inc. We count 124 filings; the first trade dates from 13 June 2007 and the latest from 8 July 2009.
The open-market side counts 122 purchases for €1.8M alongside 2 sales for €633k. Purchases outweigh sales by €1.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2009 alone, the filings show 26 purchases and 2 sales.
In size, the median ticket on the buying side is €5,203.
The newest entry dates from 24 July 2009: an open-market sale of €185k, in Seelos Therapeutics, Inc. The last insider purchase was made public on 18 February 2009, 6,472 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jacob May
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 shares@ US$0.1708Common StockSEC:0001064225-09-000001:0
- 2,620,900 shares@ US$0.24Common StockSEC:0001064225-09-000001:1
- 100,000 shares@ US$0.1382Common StockSEC:0001404089-09-000002:0Canonical exit: 4 May 2009 (T+90)
- 9,000 shares@ US$0.1395Common StockSEC:0001404089-09-000002:1Canonical exit: 4 May 2009 (T+90)
- 351,862 shares@ US$0.1523Common StockSEC:0001404089-09-000002:2Canonical exit: 4 May 2009 (T+90)
- 9,000 shares@ US$0.1625Common StockSEC:0001404089-09-000002:3Canonical exit: 4 May 2009 (T+90)
- 9,000 shares@ US$0.15Common StockSEC:0001404089-09-000002:4Canonical exit: 4 May 2009 (T+90)
- 81,501 shares@ US$0.135Common StockSEC:0001404089-09-000002:5Canonical exit: 5 May 2009 (T+90)
- 50,000 shares@ US$0.132Common StockSEC:0001404089-09-000002:6Canonical exit: 6 May 2009 (T+90)
- 150,000 shares@ US$0.136Common StockSEC:0001404089-09-000001:0Canonical exit: 25 Jan 2009 (T+90)
- 61,459 shares@ US$0.064Common StockSEC:0001404089-09-000001:1Canonical exit: 17 Feb 2009 (T+90)
- 20,751 shares@ US$0.062Common StockSEC:0001404089-09-000001:2Canonical exit: 18 Feb 2009 (T+90)
- 34,900 shares@ US$0.065Common StockSEC:0001404089-09-000001:3Canonical exit: 19 Feb 2009 (T+90)
- 20,000 shares@ US$0.075Common StockSEC:0001404089-09-000001:4Canonical exit: 24 Feb 2009 (T+90)
- 50,000 shares@ US$0.072Common StockSEC:0001404089-09-000001:5Canonical exit: 19 Feb 2009 (T+90)
- 100,000 shares@ US$0.14Common StockSEC:0001404089-09-000001:6Canonical exit: 1 Jan 2009 (T+90)
- 134,000 shares@ US$0.127Common StockSEC:0001404089-09-000001:7Canonical exit: 5 Jan 2009 (T+90)
- 77,000 shares@ US$0.12Common StockSEC:0001404089-09-000001:8Canonical exit: 6 Jan 2009 (T+90)
- 18,000 shares@ US$0.125Common StockSEC:0001404089-09-000001:9Canonical exit: 7 Jan 2009 (T+90)
- 57,300 shares@ US$0.128Common StockSEC:0001404089-09-000001:10Canonical exit: 12 Jan 2009 (T+90)
- 44,116 shares@ US$0.123Common StockSEC:0001404089-09-000001:11Canonical exit: 25 Jan 2009 (T+90)
- 7,000 shares@ US$0.125Common StockSEC:0001404089-09-000001:12Canonical exit: 26 Jan 2009 (T+90)
- 100,000 shares@ US$0.092Common StockSEC:0001404089-09-000001:13Canonical exit: 12 Feb 2009 (T+90)
- 149,100 shares@ US$0.069Common StockSEC:0001404089-09-000001:14Canonical exit: 16 Feb 2009 (T+90)
- 60,000 shares@ US$0.066Common StockSEC:0001404089-09-000001:15Canonical exit: 17 Feb 2009 (T+90)
25 of 121 declarations
